Search Results

AdventHealth will be a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ENSEMBLE trial, to evaluate the safety and efficacy of Janssen’s investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S.

In an effort to better serve our Spanish-speaking audience, the AdventHealth Morning Briefing now has a companion broadcast in Spanish.

– This morning on the AdventHealth Morning Briefing, Dr. Michael Westerveld, neuropsychologist and psychologist at AdventHealth for Children, discussed the emotional and mental effects COVID-19 is having on children and adults.

AdventHealth Hendersonville is excited to share that is has received two grants to support its efforts to increase access to behavioral health care for women in our community. The funding includes a $25,000.00 grant from The Community Foundation of Henderson County along with an additional $25,000...

The health care system has signed an eight-year deal for the naming rights for the premier indoor sporting arena.

This morning on the AdventHealth Morning Briefing, Dr. Michael Keating, chief medical officer at AdventHealth for Children, discussed rising cases of COVID-19 among younger people in the 15-24 and 25-34 age groups.

1,806 solar panel array is largest and first on-site solar project for the health care organization.

AdventHealth Changes Visitor Restrictions